The Scientific Advisory Board (SAB) of ECRI consists of like-minded cardiologists, scientists, and statisticians pursuing the design and execution of relevant and innovative cardiovascular clinical trials. The SAB includes clinical trialists from the European continent and distinguished Faculty from other continents, in an effort to co-design trans-Atlantic or global clinical investigations. The Executive Committee of the SAB includes the ECRI Managing Director and the SAB Chairman. SAB membership is pro bono and by invitation only.
Click on the names for more information:
Rotterdam, The Netherlands
Erasmus University Medical Center
Great Britain, Oxford
Oxford University Hospital
Barcelona, Spain
University Hospital Germans Trias i Pujol
Laval University
Québec, Canada
Rotterdam, The Netherlands
European Cardiovascular Research Institute
Atlanta, Georgia
Piedmont Heart Institute and Cardiovascular Service Line
Rotterdam, The Netherlands
Erasmus University Medical Center,
Milan, Italy
IRCCS Policlinico San Donato
Santander, Spain
Hospital Univeristario Marqués de Valdecilla
Genève, Switzerland
Hôpitaux Universitaires de Genève